Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer
<p>Abstract</p> <p>Background</p> <p>Increased health care costs have made it incumbent on health-care facilities and physicians to demonstrate both clinical and cost efficacy when recommending treatments. Though studies have examined the cost-effectiveness of adjuvant goserelin with radiotherapy fo...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMC
2012-01-01
|
| Colecção: | BMC Cancer |
| Assuntos: | |
| Acesso em linha: | http://www.biomedcentral.com/1471-2407/12/33 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|